ASSET PURCHASE AGREEMENT by and between Ayala Pharmaceuticals, Inc. and Immunome, Inc. Dated as of February 5, 2024Asset Purchase Agreement • February 6th, 2024 • Immunome Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made as of February 5, 2024 (the “Agreement Date”), by and between Ayala Pharmaceuticals, Inc., a Delaware corporation (“Seller”), and Immunome, Inc., a Delaware corporation (“Purchaser”). Seller and Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
SUPPORT AGREEMENTSupport Agreement • February 6th, 2024 • Immunome Inc. • Pharmaceutical preparations • Delaware
This Support Agreement (this “Agreement”) is made as of February 5, 2024, by and among Ayala Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Immunome, Inc., a Delaware corporation (“Purchaser”), and the Person or Persons set forth on the signature page hereto (“Stockholder”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Purchase Agreement.
